VCV002506259.1 - ClinVar

NM_001348323.3(TRIP12):c.6008-6A>G

Germline

Classification

The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.

(1)

Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.

Uncertain significance

criteria provided, single submitter

Somatic

No data submitted for somatic clinical impact

Somatic

No data submitted for oncogenicity

Variant Details

Identifiers

NM_001348323.3(TRIP12):c.6008-6A>G

Variation ID: 2506259 Accession: VCV002506259.1

Type and length

single nucleotide variant, 1 bp

Location

Cytogenetic: 2q36.3 2: 229767756 (GRCh38) [ NCBI UCSC ] 2: 230632472 (GRCh37) [ NCBI UCSC ]

Timeline in ClinVar

	First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.	Last submission Help The date of the most recent submission for each type of classification for this variant.	Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline	Jun 24, 2023	Jun 24, 2023	May 11, 2023

HGVS

Nucleotide	Protein	Molecular consequence
NM_001348323.3:c.6008-6A>G MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.		intron variant
NM_001284214.2:c.5927-6A>G		intron variant
NM_001284215.2:c.5882-6A>G		intron variant
NM_001284216.2:c.4973-6A>G		intron variant
NM_001348315.2:c.5927-6A>G		intron variant
NM_001348316.2:c.5882-6A>G		intron variant
NM_001348317.1:c.5867-6A>G		intron variant
NM_001348318.2:c.5867-6A>G		intron variant
NM_001348319.1:c.5993-6A>G		intron variant
NM_001348320.2:c.5993-6A>G		intron variant
NM_001348321.1:c.5996-6A>G		intron variant
NM_001348322.1:c.6008-6A>G		intron variant
NM_001348324.2:c.6008-6A>G		intron variant
NM_001348325.2:c.6008-6A>G		intron variant
NM_001348326.2:c.6008-6A>G		intron variant
NM_001348327.2:c.6008-6A>G		intron variant
NM_001348328.1:c.6011-6A>G		intron variant
NM_001348329.2:c.6011-6A>G		intron variant
NM_001348330.2:c.6011-6A>G		intron variant
NM_001348331.1:c.5786-6A>G		intron variant
NM_001348332.1:c.5906-6A>G		intron variant
NM_001348333.1:c.5930-6A>G		intron variant
NM_004238.3:c.5783-6A>G		intron variant
NC_000002.12:g.229767756T>C
NC_000002.11:g.230632472T>C
NG_053017.1:g.160479A>G

... more HGVS ... less HGVS

Protein change

Other names

Canonical SPDI

NC_000002.12:229767755:T:C

Functional consequence Help The effect of the variant on RNA or protein function, based on experimental evidence from submitters.

Global minor allele frequency (GMAF) Help The global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.

Allele frequency Help The frequency of the allele represented by this VCV record.

Links

VarSome

Genes

Gene	OMIM	ClinGen Gene Dosage Sensitivity Curation		Variation Viewer Help Links to Variation Viewer, a genome browser to view variation data from NCBI databases.	Related variants
Gene	OMIM	HI score Help The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team.	TS score Help The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team.		Within gene Help The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants.	All Help The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene.
TRIP12		Sufficient evidence for dosage pathogenicity	No evidence available	GRCh38 GRCh37	441	495

Conditions - Germline

Condition Help The condition for this variant-condition (RCV) record in ClinVar.	Classification Help The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions)	Review status Help The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status.	Last evaluated Help The most recent date that a submitter evaluated this variant for the condition.	Variation/condition record Help The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page.
not specified	Uncertain significance (1)	criteria provided, single submitter	May 11, 2023	RCV003236490.1

Submissions - Germline

Classification Help The submitted germline classification for each SCV record. (Last evaluated)	Review status Help Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria)	Condition Help The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant.	Submitter Help The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar.	More information Help This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter.
Uncertain significance (May 11, 2023)	criteria provided, single submitter (LabCorp Variant Classification Summary - May 2015) Method: clinical testing	not specified Affected status: unknown Allele origin: germline	Women's Health and Genetics/Laboratory Corporation of America, LabCorp Accession: SCV003934773.1 First in ClinVar: Jun 24, 2023 Last updated: Jun 24, 2023	Comment: Variant summary: TRIP12 c.6008-6A>G alters a non-conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly … (more) Variant summary: TRIP12 c.6008-6A>G alters a non-conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. 4/4 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant was absent in 233492 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.6008-6A>G in individuals affected with Clark-Baraitser Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance. (less)

Comment:

Variant summary: TRIP12 c.6008-6A>G alters a non-conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. 4/4 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant was absent in 233492 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.6008-6A>G in individuals affected with Clark-Baraitser Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance.

Germline Functional Evidence

There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar.

Comment:

Citations for germline classification of this variant

There are no citations for germline classification of this variant in ClinVar. If you know of citations for this variation, please consider submitting that information to ClinVar.

Text-mined citations for this variant ...

Record last updated Jun 24, 2023

ClinVar Genomic variation as it relates to human health

NM_001348323.3(TRIP12):c.6008-6A>G

Variant Details

Genes

Conditions - Germline

Submissions - Germline

Germline Functional Evidence

Citations for germline classification of this variant

Text-mined citations for this variant ...